PARP1 and ovarian carcinoma: Surprisingly, we showed that even in the presence of a PARPi, NR1D1 overexpression was able to significantly inhibit HR, suggesting that the regulation of DNA repair by NR1D1 in ovarian cancer is not solely dependent on PARP1.